Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
AstraZeneca
Teva
Cerilliant
Express Scripts
US Department of Justice
McKinsey
Johnson and Johnson
Fuji

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017669

« Back to Dashboard

NDA 017669 describes TENUATE, which is a drug marketed by Sanofi Aventis Us and Actavis Labs Ut Inc and is included in four NDAs. It is available from six suppliers. Additional details are available on the TENUATE profile page.

The generic ingredient in TENUATE is diethylpropion hydrochloride. There are eleven drug master file entries for this compound. Thirteen suppliers are listed for this compound. Additional details are available on the diethylpropion hydrochloride profile page.
Summary for 017669
Tradename:TENUATE
Applicant:Sanofi Aventis Us
Ingredient:diethylpropion hydrochloride
Patents:0
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 017669

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET, EXTENDED RELEASE;ORALStrength75MG
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

UBS
Express Scripts
Cerilliant
AstraZeneca
Boehringer Ingelheim
Citi
Covington
Chubb
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.